North America Tumor Ablation Market By Treatment (Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation) By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology) By Application (Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer) By Country, Industry Analysis and Forecast, 2019 - 2025
The North America Tumor Ablation Market would witness market growth of 9.4% CAGR during the forecast period (2019-2025).
Tumor ablation treatment is an excellent option over many other conventional treatment methods owing to its minimal invasiveness. For patients who are unable to undergo surgery due to medical reasons, it has been considered the best choice. It is highly effective and safe in treating patients with four or few tumors confined to a small region, chemotherapy is considered more effective for larger and greater numbers of tumors. One of the facilitating factors of the revolutionary treatment has been the high success rate of tumor ablation, which also makes it one of the most favored tumor therapies where other therapies might not be effective for multiple reasons. The procedure of tumor ablation has been used to treat different types of cancer such as colorectal cancer, lung cancer, liver cancer, prostate cancer, etc.
Microwave tumor ablation technology has been the fastest-growing category of ablation technology currently used to manage various cancers (like lung, liver, and kidney). Growth in the microwave ablation segment can be attributed to increased private funding for new microwave ablation product development, drastic efficiency over other ablation technologies, and increased adoption by Healthcare professionals of the microwave tumor ablation procedure to treat different cancers.
The percutaneous ablation techniques are well known in cancer treatment for both cure and local regulation of many forms of tumors. Tumor tissue cryoablation leads to cell destruction by freezing. Cryoablation leads to tumor cell death by osmosis and necrosis, in comparison to heat-based ablative modalities. It is observed that the intracellular contents of cancer cells remain intact with necrosis allowing an immune-specific reaction to being induced by the immune system.
Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.
Scope of the Study
Market Segmentation:
By Treatment
Tumor ablation treatment is an excellent option over many other conventional treatment methods owing to its minimal invasiveness. For patients who are unable to undergo surgery due to medical reasons, it has been considered the best choice. It is highly effective and safe in treating patients with four or few tumors confined to a small region, chemotherapy is considered more effective for larger and greater numbers of tumors. One of the facilitating factors of the revolutionary treatment has been the high success rate of tumor ablation, which also makes it one of the most favored tumor therapies where other therapies might not be effective for multiple reasons. The procedure of tumor ablation has been used to treat different types of cancer such as colorectal cancer, lung cancer, liver cancer, prostate cancer, etc.
Microwave tumor ablation technology has been the fastest-growing category of ablation technology currently used to manage various cancers (like lung, liver, and kidney). Growth in the microwave ablation segment can be attributed to increased private funding for new microwave ablation product development, drastic efficiency over other ablation technologies, and increased adoption by Healthcare professionals of the microwave tumor ablation procedure to treat different cancers.
The percutaneous ablation techniques are well known in cancer treatment for both cure and local regulation of many forms of tumors. Tumor tissue cryoablation leads to cell destruction by freezing. Cryoablation leads to tumor cell death by osmosis and necrosis, in comparison to heat-based ablative modalities. It is observed that the intracellular contents of cancer cells remain intact with necrosis allowing an immune-specific reaction to being induced by the immune system.
Based on Treatment, the market is segmented into Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Based on Technology, the market is segmented into Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation and Other Technology. Based on Application, the market is segmented into Liver Cancer, Breast Cancer, Lung Cancer, Kidney Cancer, Prostate Cancer and Other Cancer. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson and Johnson (Ethicon, Inc.), Boston Scientific Corporation, Misonix, Inc., EDAP TMS S.A., Theraclion SA, AngioDynamics, Inc., Mermaid Medical A/S, HealthTronics, Inc. (Altaris Capital Partners, LLC), and SonaCare Medical, LLC.
Scope of the Study
Market Segmentation:
By Treatment
- Surgical Ablation
- Laparoscopic Ablation and
- Percutaneous Ablation
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Irreversible Electroporation and
- Other Technology
- Liver Cancer
- Breast Cancer
- Lung Cancer
- Kidney Cancer
- Prostate Cancer and
- Other Cancer
- US
- Canada
- Mexico
- Rest of North America
- Medtronic PLC
- Johnson and Johnson (Ethicon, Inc.)
- Boston Scientific Corporation
- Misonix, Inc.
- EDAP TMS S.A.
- Theraclion SA
- AngioDynamics, Inc.
- Mermaid Medical A/S
- HealthTronics, Inc. (Altaris Capital Partners, LLC)
- SonaCare Medical, LLC
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Tumor Ablation Market, by Treatment
1.4.2 North America Tumor Ablation Market, by Technology
1.4.3 North America Tumor Ablation Market, by Application
1.4.4 North America Tumor Ablation Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Oct – 2016-Jan) Leading Players
CHAPTER 4. NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT
4.1 North America Surgical Ablation Market by Country
4.2 North America Laparoscopic Ablation Market by Country
4.3 North America Percutaneous Ablation Market by Country
CHAPTER 5. NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY
5.1 North America Radiofrequency Ablation Market by Country
5.2 North America Microwave Ablation Market by Country
5.3 North America Cryoablation Market by Country
5.4 North America Irreversible Electroporation Market by Country
5.5 North America Other Technology Market by Country
CHAPTER 6. NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION
6.1 North America Liver Cancer Market by Country
6.2 North America Breast Cancer Market by Country
6.3 North America Lung Cancer Market by Country
6.4 North America Kidney Cancer Market by Country
6.5 North America Prostate Cancer Market by Country
6.6 North America Others Tumor Ablation Market by Country
CHAPTER 7. NORTH AMERICA TUMOR ABLATION MARKET BY COUNTRY
7.1 US Tumor Ablation Market
7.1.1 US Tumor Ablation Market by Treatment
7.1.2 US Tumor Ablation Market by Technology
7.1.3 US Tumor Ablation Market by Application
7.2 Canada Tumor Ablation Market
7.2.1 Canada Tumor Ablation Market by Treatment
7.2.2 Canada Tumor Ablation Market by Technology
7.2.3 Canada Tumor Ablation Market by Application
7.3 Mexico Tumor Ablation Market
7.3.1 Mexico Tumor Ablation Market by Treatment
7.3.2 Mexico Tumor Ablation Market by Technology
7.3.3 Mexico Tumor Ablation Market by Application
7.4 Rest of North America Tumor Ablation Market
7.4.1 Rest of North America Tumor Ablation Market by Treatment
7.4.2 Rest of North America Tumor Ablation Market by Technology
7.4.3 Rest of North America Tumor Ablation Market by Application
CHAPTER 8. COMPANY PROFILES
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 Johnson and Johnson (Ethicon, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.1 Recent strategies and developments:
8.2.1.1 Acquisition and Mergers:
8.2.1.2 Product Launches and Product Expansions:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Misonix, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 EDAP TMS S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Theraclion SA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.7 AngioDynamics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Mermaid Medical A/S
8.8.1 Company Overview
8.9 HealthTronics, Inc. (Altaris Capital Partners, LLC)
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.9.2.2 Partnerships, Collaborations, and Agreements:
8.1 SonaCare Medical, LLC
8.10.1 Company overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Tumor Ablation Market, by Treatment
1.4.2 North America Tumor Ablation Market, by Technology
1.4.3 North America Tumor Ablation Market, by Application
1.4.4 North America Tumor Ablation Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Oct – 2016-Jan) Leading Players
CHAPTER 4. NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT
4.1 North America Surgical Ablation Market by Country
4.2 North America Laparoscopic Ablation Market by Country
4.3 North America Percutaneous Ablation Market by Country
CHAPTER 5. NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY
5.1 North America Radiofrequency Ablation Market by Country
5.2 North America Microwave Ablation Market by Country
5.3 North America Cryoablation Market by Country
5.4 North America Irreversible Electroporation Market by Country
5.5 North America Other Technology Market by Country
CHAPTER 6. NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION
6.1 North America Liver Cancer Market by Country
6.2 North America Breast Cancer Market by Country
6.3 North America Lung Cancer Market by Country
6.4 North America Kidney Cancer Market by Country
6.5 North America Prostate Cancer Market by Country
6.6 North America Others Tumor Ablation Market by Country
CHAPTER 7. NORTH AMERICA TUMOR ABLATION MARKET BY COUNTRY
7.1 US Tumor Ablation Market
7.1.1 US Tumor Ablation Market by Treatment
7.1.2 US Tumor Ablation Market by Technology
7.1.3 US Tumor Ablation Market by Application
7.2 Canada Tumor Ablation Market
7.2.1 Canada Tumor Ablation Market by Treatment
7.2.2 Canada Tumor Ablation Market by Technology
7.2.3 Canada Tumor Ablation Market by Application
7.3 Mexico Tumor Ablation Market
7.3.1 Mexico Tumor Ablation Market by Treatment
7.3.2 Mexico Tumor Ablation Market by Technology
7.3.3 Mexico Tumor Ablation Market by Application
7.4 Rest of North America Tumor Ablation Market
7.4.1 Rest of North America Tumor Ablation Market by Treatment
7.4.2 Rest of North America Tumor Ablation Market by Technology
7.4.3 Rest of North America Tumor Ablation Market by Application
CHAPTER 8. COMPANY PROFILES
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Acquisition and Mergers:
8.1.5.2 Product Launches and Product Expansions:
8.2 Johnson and Johnson (Ethicon, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.1 Recent strategies and developments:
8.2.1.1 Acquisition and Mergers:
8.2.1.2 Product Launches and Product Expansions:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Misonix, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.5 EDAP TMS S.A.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Theraclion SA
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.7 AngioDynamics, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.8 Mermaid Medical A/S
8.8.1 Company Overview
8.9 HealthTronics, Inc. (Altaris Capital Partners, LLC)
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisition and Mergers:
8.9.2.2 Partnerships, Collaborations, and Agreements:
8.1 SonaCare Medical, LLC
8.10.1 Company overview
LIST OF TABLES
TABLE 1 NORTH AMERICA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– TUMOR ABLATION MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– TUMOR ABLATION MARKET
TABLE 5 MERGERS & ACQUISITIONS – TUMOR ABLATION MARKET
TABLE 6 NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 7 NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 8 NORTH AMERICA SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 9 NORTH AMERICA SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 10 NORTH AMERICA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 11 NORTH AMERICA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 12 NORTH AMERICA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 13 NORTH AMERICA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 14 NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 15 NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 16 NORTH AMERICA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 17 NORTH AMERICA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 18 NORTH AMERICA MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 19 NORTH AMERICA MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 20 NORTH AMERICA CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 21 NORTH AMERICA CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 22 NORTH AMERICA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 23 NORTH AMERICA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 24 NORTH AMERICA OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 25 NORTH AMERICA OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 26 NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 27 NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 28 NORTH AMERICA LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 29 NORTH AMERICA LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 30 NORTH AMERICA BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 31 NORTH AMERICA BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 32 NORTH AMERICA LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 33 NORTH AMERICA LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 34 NORTH AMERICA KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 35 NORTH AMERICA KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 36 NORTH AMERICA PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 37 NORTH AMERICA PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 38 NORTH AMERICA OTHERS TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 39 NORTH AMERICA OTHERS TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 40 NORTH AMERICA TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 41 NORTH AMERICA TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 42 US TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 43 US TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 44 US TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 45 US TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 46 US TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 47 US TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 48 US TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 49 US TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 50 CANADA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 51 CANADA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 52 CANADA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 53 CANADA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 54 CANADA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 55 CANADA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 56 CANADA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 57 CANADA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 58 MEXICO TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 59 MEXICO TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 60 MEXICO TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 61 MEXICO TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 62 MEXICO TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 63 MEXICO TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 64 MEXICO TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 65 MEXICO TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 66 REST OF NORTH AMERICA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 67 REST OF NORTH AMERICA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 68 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 69 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 70 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 71 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 72 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 73 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 74 KEY INFORMATION – MEDTRONIC PLC
TABLE 75 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 76 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 77 KEY INFORMATION – MISONIX, INC.
TABLE 78 KEY INFORMATION – EDAP TMS S.A.
TABLE 79 KEY INFORMATION – THERACLION SA
TABLE 80 KEY INFORMATION – ANGIODYNAMICS, INC.
TABLE 81 KEY INFORMATION – MERMAID MEDICAL A/S
TABLE 82 KEY INFORMATION – HEALTHTRONICS, INC.
TABLE 83 KEY INFORMATION – SONACARE MEDICAL, LLC
TABLE 1 NORTH AMERICA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– TUMOR ABLATION MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– TUMOR ABLATION MARKET
TABLE 5 MERGERS & ACQUISITIONS – TUMOR ABLATION MARKET
TABLE 6 NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 7 NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 8 NORTH AMERICA SURGICAL ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 9 NORTH AMERICA SURGICAL ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 10 NORTH AMERICA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 11 NORTH AMERICA LAPAROSCOPIC ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 12 NORTH AMERICA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 13 NORTH AMERICA PERCUTANEOUS ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 14 NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 15 NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 16 NORTH AMERICA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 17 NORTH AMERICA RADIOFREQUENCY ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 18 NORTH AMERICA MICROWAVE ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 19 NORTH AMERICA MICROWAVE ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 20 NORTH AMERICA CRYOABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 21 NORTH AMERICA CRYOABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 22 NORTH AMERICA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 23 NORTH AMERICA IRREVERSIBLE ELECTROPORATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 24 NORTH AMERICA OTHER TECHNOLOGY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 25 NORTH AMERICA OTHER TECHNOLOGY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 26 NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 27 NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 28 NORTH AMERICA LIVER CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 29 NORTH AMERICA LIVER CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 30 NORTH AMERICA BREAST CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 31 NORTH AMERICA BREAST CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 32 NORTH AMERICA LUNG CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 33 NORTH AMERICA LUNG CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 34 NORTH AMERICA KIDNEY CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 35 NORTH AMERICA KIDNEY CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 36 NORTH AMERICA PROSTATE CANCER MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 37 NORTH AMERICA PROSTATE CANCER MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 38 NORTH AMERICA OTHERS TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 39 NORTH AMERICA OTHERS TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 40 NORTH AMERICA TUMOR ABLATION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 41 NORTH AMERICA TUMOR ABLATION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 42 US TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 43 US TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 44 US TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 45 US TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 46 US TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 47 US TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 48 US TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 49 US TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 50 CANADA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 51 CANADA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 52 CANADA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 53 CANADA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 54 CANADA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 55 CANADA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 56 CANADA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 57 CANADA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 58 MEXICO TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 59 MEXICO TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 60 MEXICO TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 61 MEXICO TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 62 MEXICO TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 63 MEXICO TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 64 MEXICO TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 65 MEXICO TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 66 REST OF NORTH AMERICA TUMOR ABLATION MARKET, 2015 - 2018, USD MILLION
TABLE 67 REST OF NORTH AMERICA TUMOR ABLATION MARKET, 2019 - 2025, USD MILLION
TABLE 68 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2015 - 2018, USD MILLION
TABLE 69 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TREATMENT, 2019 - 2025, USD MILLION
TABLE 70 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2015 - 2018, USD MILLION
TABLE 71 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY TECHNOLOGY, 2019 - 2025, USD MILLION
TABLE 72 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 73 REST OF NORTH AMERICA TUMOR ABLATION MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 74 KEY INFORMATION – MEDTRONIC PLC
TABLE 75 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 76 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 77 KEY INFORMATION – MISONIX, INC.
TABLE 78 KEY INFORMATION – EDAP TMS S.A.
TABLE 79 KEY INFORMATION – THERACLION SA
TABLE 80 KEY INFORMATION – ANGIODYNAMICS, INC.
TABLE 81 KEY INFORMATION – MERMAID MEDICAL A/S
TABLE 82 KEY INFORMATION – HEALTHTRONICS, INC.
TABLE 83 KEY INFORMATION – SONACARE MEDICAL, LLC
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-OCT – 2016-JAN) LEADING PLAYERS
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-OCT – 2016-JAN) LEADING PLAYERS
